Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis

INTRODUCTION: Cell-based therapies potentially delay the trajectory toward end-stage kidney disease (ESKD) in late stage 4 diabetic chronic kidney disease (DKD). We describe the trial design, baseline patient characteristics, and early results of an IRB-approved phase II multicenter clinical trial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stavas, Joseph, Thajudeen, Bijin, Coca, Steven, Silva, Arnold, Butler, Emily, Detwiler, Randal, Burgner, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932837/
https://www.ncbi.nlm.nih.gov/pubmed/36599315
http://dx.doi.org/10.1159/000527582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932837/
https://www.ncbi.nlm.nih.gov/pubmed/36599315
http://dx.doi.org/10.1159/000527582

Ejemplares similares